WITHDRAWN

Identification of Novel Markers of Human Lung Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to investigate new therapies for advanced lung disease.

Official Title

Identification of Novel Markers of Human Lung Disease

Quick Facts

Study Start:2015-02
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:WITHDRAWN

Study ID

NCT02369575

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * any one on lung transplant list
  1. * HIV positive

Contacts and Locations

Principal Investigator

Megan Ballinger
PRINCIPAL_INVESTIGATOR
Ohio State University

Study Locations (Sites)

Davis Heart and Lung Research Institute
Columbus, Ohio, 43210
United States

Collaborators and Investigators

Sponsor: Ohio State University

  • Megan Ballinger, PRINCIPAL_INVESTIGATOR, Ohio State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-02
Study Completion Date2025-07

Study Record Updates

Study Start Date2015-02
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Diseases, Interstitial